Lazdina Una, Hultgren Catharina, Frelin Lars, Chen Margaret, Lodin Karin, Weiland Ola, Leroux-Roels Geert, Quiroga Juan A, Peterson Darrell L, Milich David R, Sällberg Matti
Divisions of Clinical Virology, F68, and Biomedical Laboratory Technology1 and Division of Infectious Diseases, Department of Medicine2, Karolinska Institute, Huddinge University Hospital, S-141 86 Huddinge, Sweden.
Department of Vaccinology, University of Ghent, Ghent, Belgium3.
J Gen Virol. 2001 Jun;82(Pt 6):1299-1308. doi: 10.1099/0022-1317-82-6-1299.
The non-structural 3 (NS3) protein is one of the most conserved proteins of hepatitis C virus, and T helper 1 (Th1)-like responses to NS3 in humans correlate with clearance of infection. Several studies have proposed that DNA-based immunizations are highly immunogenic and prime Th1-like responses, although few head-to-head comparisons with exogenous protein immunizations have been described. A full-length NS3/NS4A gene was cloned in eukaryotic vectors with expression directed to different subcellular compartments. Inbred mice were immunized twice in regenerating tibialis anterior (TA) muscles with either plasmid DNA or recombinant NS3 (rNS3). After two 100 micrograms DNA immunizations, specific antibody titres of up to 12960 were detected at week 5, dominated by IgG2a and IgG2b. NS3-specific CD4(+) T cell responses in DNA-immunized mice peaked at day 13, as measured by proliferation and IL-2 and IFN-gamma production. Mice immunized with 1-10 micrograms rNS3 without adjuvant developed antibody titres comparable to those of the DNA-immunized mice, but dominated instead by IgG1. CD4(+) T cell responses in these mice showed peaks of IL-2 response at day 3 and IL-6 and IFN-gamma responses at day 6. With adjuvant, rNS3 was around 10-fold more immunogenic with respect to speed and magnitude of the immune responses. Thus, immunization with rNS3 in adjuvant is superior to DNA immunization with respect to kinetics and quantity in priming specific antibodies and CD4(+) T cells. However, as a DNA immunogen, NS3 elicits stronger Th1-like immune responses, whereas rNS3 primes a mixed Th1/Th2-like response regardless of the route, dose or adjuvant.
非结构3(NS3)蛋白是丙型肝炎病毒中最保守的蛋白之一,人类对NS3的1型辅助性T细胞(Th1)样反应与感染清除相关。多项研究表明,基于DNA的免疫具有高度免疫原性并引发Th1样反应,不过与外源性蛋白免疫的直接比较描述较少。将全长NS3/NS4A基因克隆到真核载体中,使其表达定位于不同的亚细胞区室。用质粒DNA或重组NS3(rNS3)对近交系小鼠的再生胫前(TA)肌进行两次免疫。两次给予100微克DNA免疫后,在第5周检测到特异性抗体滴度高达12960,以IgG2a和IgG2b为主。通过增殖以及白细胞介素-2(IL-2)和干扰素-γ(IFN-γ)产生来衡量,DNA免疫小鼠中NS3特异性CD4(+) T细胞反应在第13天达到峰值。用1 - 10微克无佐剂rNS3免疫的小鼠产生的抗体滴度与DNA免疫小鼠相当,但以IgG1为主。这些小鼠中的CD4(+) T细胞反应在第3天显示IL-2反应峰值,在第6天显示IL-6和IFN-γ反应峰值。使用佐剂时,rNS3在免疫反应的速度和强度方面免疫原性约高10倍。因此,在引发特异性抗体和CD4(+) T细胞方面,使用佐剂的rNS3免疫在动力学和数量上优于DNA免疫。然而,作为DNA免疫原,NS3引发更强的Th1样免疫反应,而rNS3无论途径、剂量或佐剂如何,均引发混合的Th1/Th2样反应。